chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine expired on 01-Apr-2022, stored in refrigerator on 04-Apr-2022 and administered on 16-Apr-2022; Expired vaccine administered to 155 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, stored in refrigerator on 04-Apr-2022 and administered on 16-Apr-2022) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, stored in refrigerator on 04-Apr-2022 and administered on 16-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, stored in refrigerator on 04-Apr-2022 and administered on 16-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. The vial was initially stored in refrigerator on 04-Apr-2022. Vial did not undergo any temperature excursion. Pharmacist called to verify an expiration date of lot number 026L21B. Pharmacist told that when  pharmacy received this vaccine on 23-Feb-2022, a pharmacy staff member looked up the expiration date and came up with an expiration date of June 2022. However another pharmacy staff member looked up the expiration date and came up with an expiration date of 01-Apr-2022. The expiry date of vaccine was confirmed as 01-Apr-2022. Pharmacist asked how to proceed in the care of the patient who received expired vaccine. No treatment medication were provided.   This case was linked to MOD-2022-551714 (Patient Link).
Pt began having fatigue, body aches, headaches, and vomited x1 about one hour after vaccine administration.  He presented to the clinic about two days after vaccination with continued fatigue, headaches, and body aches.
Pt was inadvertently inject w/ MMR II mixed w/ HAEM inf B VAX ON 07SEP90.
Starting 2:30 am, woke up nauseated, severe chills.  Vomited 3am, severe chills, headache, body aches  all night.  Severe Body aches and headache lasted all next day.  Leg aches became extreme next night.  Following night, I still had chills, body aches, headache.  Second morning, I am still having headache, moderate body aches
After two weeks, I got weakness in my legs and arms and headaches. Also, I got stiffness in my neck and paralysis that comes and goes throughout the day. Loss of feeling in my arms and legs that hasn?t come back. Both hands are locking up. Dizziness
Starting in late March of 2022 I started to feel strange hearbeats (later to learn palpitations) and then an elevated heartbeat that would not come down below 100 even while sleeping (resting usually 60).  I went to the emergency room where it was discovered that my thyroid levels were very high.  I later saw my GP and he tested my antibodies and diagnosed with Grave's Disease (March 28).  I now see a Endocrinologist who confirmed the Grave's diagnosis.
77-year-old male presents emergency department today for chief complaint of difficulty in breathing.  This patient states he has had shortness of breath for the past several days has gotten much worse.  He states that 9 days ago he developed symptoms of COVID-19.
Began to react to shot the first night about 3am (9/21, Thursday).  Had swelling and tenderness of axillary lymph nodes and breasts on both sides of body.  Had shallow breathing due to the swelling and pain.  Ended up in a recliner, due to discomfort.  Very uncomfortable and unable to sleep.  Thursday in am, had increased tenderness and swelling which also involved both arms.  Left arm-  being unable to lift left arm above shoulder height.   Took Tylenol extra strength.   Next day Friday, both hips were also extremely sore and painful... I took a flexeril and extra strength Tylenol.  Continued flexural and Tylenol Saturday, Sunday, Monday and Tuesday 9/26/23.   The extreme discomfort, swelling and painful lymph nodes  seem to be gone.  Now just weak, but no pain or swelling.      From Thursday 9/21  through Monday 9/25/23 I spent most of time on bedrest.   No respiratory symptoms.   covid home tests x 2 were negative.
breakthrough infection; This spontaneous case was reported by a physician and describes the occurrence of VACCINE BREAKTHROUGH INFECTION (breakthrough infection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINE BREAKTHROUGH INFECTION (breakthrough infection). At the time of the report, VACCINE BREAKTHROUGH INFECTION (breakthrough infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Patient received a breakthrough covid-19 infection after receiving the Moderna covid-19 vaccine primary series. Unknown dates of vaccination, unknown lot numbers, unknown patient information.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. No medical history, concurrent conditions and concomitant medications were reported. On unknown dates, multiple unspecified patients were vaccinated with PNEUMOVAX 23, lot # K007824, expiration date: 05-NOV-2015, (dose, adminsitration route and site were not reported) after it was exposed to a supported temperature excursion of 32.9F for 2 hours and 45 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Receiving the second dose of the vaccine after day 36 from the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving the second dose of the vaccine after day 36 from the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving the second dose of the vaccine after day 36 from the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receiving the second dose of the vaccine after day 36 from the first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
feels like ears and head are plugged Achy all over Feels chilled Flu shot last year did not bother her   Also hoarse with sinus drainage: took allegra yesterday [post nasal] Was a little lightheaded Chest feels congested (history of "bronchitis")   Nasal passage is clear: not stuffy or runny   Was at a funeral Saturday: masked in doors, not outdoors Careful hand hygiene   She states taht when her temp is ~ 99 it is like it is 103 for her.   +prior ENT care for rhinitis and post nasal drainage   Review of Systems  Constitutional: Positive for chills. Negative for fever.  HENT: Positive for ear pain and tinnitus. Negative for sore throat ("scratchy").   Respiratory: Negative for cough.
I had a mild headache the evening of the shot, I had a headache the next two days that was relieved by Advil. I had a very sore arm at the injection site Friday and Saturday after the shot was given. The arm pain was gone Sunday morning.  I was very tired on Saturday especially and slept through the morning and early afternoon on and off until about 3:00 pm. On Friday during the day, I noticed my right ear starting to feel unusual and uncomfortable.  On Saturday, the ear issue continued, I felt like I had some hearing loss and a constant buzzing and ear fullness feeling.  On Sunday, the ear issued continued with the hearing loss, buzzing and fullness and has through today and hasn't stopped.  I tried some nasal decongestant on Sunday afternoon, but it didn't have any effect.  I made an appointment with the ENT doctor on Monday morning for Tuesday.  I had a hearing test on Tuesday and saw the ENT doctor on Wednesday.  He prescribed prednisone and ordered an MRI.  I will be starting the prednisone later today (Wednesday) when the pharmacy has the prescription ready.
Initial report received from a healthcare professional on 13 May 2014. A '19-year-old' female patient, whose medical history and concomitant medication was not reported, had received the first dose of pre exposure series of IMOVAX (IPV (VERO)) (lot number J1391-1, expiration date, and route of vaccination was not reported) in to the left deltoid, and a dose of YF-VAX (Lot number UH675AA, expiration date, and route of vaccination was not reported) in to the right deltoid on 06 May 2014, and patient had experienced achiness, itchy around injection site, tiredness, large red oblong area about 2 in. long x 1.5 in, wide, slightly raised around injection site on 07 May 2014. It was reported that the patient's symptoms was ongoing at the time of report. The detail of laboratory investigation and corrective treatment was not reported. The outcome of event was not recovered at the time of report. List of documents held by sender: none.
Sore arm after each dose; very mild flu like symptoms after each dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after each dose) and INFLUENZA LIKE ILLNESS (very mild flu like symptoms after each dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after each dose) and INFLUENZA LIKE ILLNESS (very mild flu like symptoms after each dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after each dose) and INFLUENZA LIKE ILLNESS (very mild flu like symptoms after each dose) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-406661, MOD-2021-406673, MOD-2021-406558 (Patient Link).
REPORTED TO WORK 10/31/2012 AT 12:30 PM D/T NOT FEELING WELL, SAID HAD DIZZINESS, H/A NAUSEA, WENT HOME, FELT BETTER WENT TO CHURCH DINNER, BEGAN FEELING SAME SX AND WENT BACK HOME STATED HAD TEMP OF 102. ON 11/01/2012 REPORTED TO WORK THEN AT 08:25 C/O DIZZINESS, H/A AND BODY ACHES. TEMP 97.2, PULSE 103, B/P 141/92. OBSERVED CHILLS AND WEAKNESS. REFUSED MEDICAL TRANSPORT.  PICKED UP BY FAMILY MEMBER.  ADVISED TO SEEK MED. ATTENTION IMMEDIATELY.
I was running a fever and I was very achy. I ended up getting COVID test and throat culture at a walk in clinic. They came back negative and it lasted for four days.
Redness, itching, warm to touch and stinging at site of injection 2 days after the shot. No fever and no other systemic symptoms
PT received Pfizer booster on 11/22/21 within 24 hours developed a red painful non raised non pruritic ring around the injection site; nausea; anxiety with panic attacks  PT states he tolerated the first two injection without the above sxs PMHx significant for MDD and GAD, however states prior anxiety was controlled and no panic attacks  meds: lamotrigine, fluoetine, buspiron, tylenol
Eight days after injection 3-4 inch slightly raised reddish  area appeared on left upper arm around site of injection.  Prior to this, other than slightly sore upper arm for 24-48 hours was the only symptom I experience.  Reddish area still present.  Area is not warm to touch, but does inch sometimes.   I have not experienced any fever at anytime since injection.
Felt like tongue was swelling; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of SWOLLEN TONGUE (Felt like tongue was swelling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWOLLEN TONGUE (Felt like tongue was swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swelling of tongue, at a dose of UNK dosage form. At the time of the report, SWOLLEN TONGUE (Felt like tongue was swelling) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product used was not provided by the reporter. Treatment included diphenhydramine.  This patient was administered the vaccine at a Pharmacy. When he felt like his tongue was swelling, the pharmacist gave him a diphenhydramine and the issue quickly dissipated.    Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Follow-up received on 22-Mar-2021 included no new information. On 20-Apr-2021: Follow-up received on 20-Apr-2021 included no new information.
I have had an IUD since 2018, which inhibits my menstruation almost completely. It is rare that I experience period symptoms. A few days after receiving the first dose of JYNNEOS, I began to experience period symptoms, most noticeably menstrual bleeding and cramping. Most of the symptoms faded within a few days, except for the menstrual bleeding, which continued for about 10 days post-vaccine dose. The volume of bleeding decreased over the course of those 10 days.
This spontaneous report as received from a pharmacist regarding unspecified number of patients of unknown age and gender. No information was provided regarding the patients medical history, concurrent conditions, previous drug reactions or concomitant medications. On an unknown date, the patients were vaccinated with PNEUMOVAX 23 (dosage, lot#, expiry date were not reported) for prophylaxis. On an unknown date, the patients experienced adverse reaction. The outcome of adverse reaction was unknown. Causality was not provided.
Swelling in arm below injection site. Swelling was warm to touch and slightly itchy. Started about a week after injection and last for about 4  days.
Pt recvd vax & the next day devel a swollen throat, lymph glands & flu-like sx; pt treated w/Atarax;
Fainting; frequent urination; MODERNA toes/dots on her foot which still persist; itchiness; Dehydration; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Fainting) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported by the reporter.  Concomitant products included DORZOLAMIDE HYDROCHLORIDE (DORZOLOMIDE HYDROCHLORIDE), TIMOLOL and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SYNCOPE (Fainting) (seriousness criterion medically significant), POLLAKIURIA (frequent urination), VACCINATION COMPLICATION (MODERNA toes/dots on her foot which still persist), PRURITUS (itchiness), DEHYDRATION (Dehydration) and PYREXIA (Fever). At the time of the report, SYNCOPE (Fainting), POLLAKIURIA (frequent urination), DEHYDRATION (Dehydration) and PYREXIA (Fever) outcome was unknown, VACCINATION COMPLICATION (MODERNA toes/dots on her foot which still persist) had not resolved and PRURITUS (itchiness) had resolved.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  Treatment medications were not reported.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MODERNATX, INC.-MOD-2021-089293 (E2B Linked Report).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. MODERNATX, INC.-MOD-2021-089293:Husband case
Patient was vaccinated with Moderna covid vaccine on 3/2/21 and 3/30/21. Patient subsequently tested positive for covid infection on 7/16/21 and 7/20/21.
breastfeeding; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) and HEADACHE (Headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and CALCIUM for an unknown indication.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) and HEADACHE (Headache). On 26-Feb-2021, MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.            Treatment information was not reported.
croupy cough 5AUG93; axillary t102.8; runny nose;
Tongue and gland swelling, fatigue, joint pain, chills, nausea, redness, soreness at injection site.  Symptoms started approximately an hour and a half to two hours after injection.  Symptoms lasted approximately three days then tapered off.
Patient received vaccine on 12/15/04 @ 7pm. Sometime after 10:30pm on 12/15/04 patient awoke from her sleep.  Patient was coughing, wheezing, and having difficulty breathing.  Patient experienced a feeling of a heavy weight on her chest.  The episode of breathing difficulty lasted approx. 2-3 hours, patient was unable to sleep during this time.
No adverse event; Received 2nd Bivalent booster, 54 days after first Bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (Received 2nd Bivalent booster, 54 days after first Bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 017H22A and AS71432) for COVID-19 vaccination.     Concurrent medical conditions included Dementia.   On 06-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Nov-2022, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXTRA DOSE ADMINISTERED (Received 2nd Bivalent booster, 54 days after first Bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (Received 2nd Bivalent booster, 54 days after first Bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (Received 2nd Bivalent booster, 54 days after first Bivalent booster).    The patient received the primary series of unknown brand of monovalent dose (dose 1 and dose 2) on an unknown date with unknown lot and expiration date. On 22-Dec-2021, the patient received the first monovalent booster dose of Moderna COVID-19 vaccine (Lot:045C21A and expiry date: 02-May-2022). On 07-Jun-2022, the patient received the second monovalent booster dose of  Moderna COVID-19 vaccine (Lot: 056M21A and expiry date: 12-Aug-2022).
altered mental status.  Pt was found sitting on lawn mower confused A o x 1-2.
1 week after having vaccine with only a sore arm initially,  I developed an uncomfortable rash at the injection site - slight swelling and burning. Topical cream helped so I did not need to seek medical attention
On the 3rd day I was sick to my stomach (cramping and diarrhea) and ran a fever of about 102. I had chills and was a bit achy. This lasted two days.
arthralgias following 2nd hep B vax-migratory involuntary hands, knees & elbow;ANA & RF, RPR negative;sed rate was 45;